JP2017504561A5 - - Google Patents

Download PDF

Info

Publication number
JP2017504561A5
JP2017504561A5 JP2016528880A JP2016528880A JP2017504561A5 JP 2017504561 A5 JP2017504561 A5 JP 2017504561A5 JP 2016528880 A JP2016528880 A JP 2016528880A JP 2016528880 A JP2016528880 A JP 2016528880A JP 2017504561 A5 JP2017504561 A5 JP 2017504561A5
Authority
JP
Japan
Prior art keywords
formula
alkyl
compound
nhr
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016528880A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017504561A (ja
JP6661533B2 (ja
Filing date
Publication date
Priority claimed from GBGB1320636.2A external-priority patent/GB201320636D0/en
Application filed filed Critical
Publication of JP2017504561A publication Critical patent/JP2017504561A/ja
Publication of JP2017504561A5 publication Critical patent/JP2017504561A5/ja
Application granted granted Critical
Publication of JP6661533B2 publication Critical patent/JP6661533B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016528880A 2013-11-22 2014-11-21 ミトコンドリアを標的とするジカルボニル捕捉化合物 Expired - Fee Related JP6661533B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1320636.2 2013-11-22
GBGB1320636.2A GB201320636D0 (en) 2013-11-22 2013-11-22 Compounds
PCT/EP2014/075323 WO2015075200A1 (en) 2013-11-22 2014-11-21 Mitochondria-targeted dicarbonyl sequestering compounds

Publications (3)

Publication Number Publication Date
JP2017504561A JP2017504561A (ja) 2017-02-09
JP2017504561A5 true JP2017504561A5 (cg-RX-API-DMAC7.html) 2017-12-28
JP6661533B2 JP6661533B2 (ja) 2020-03-11

Family

ID=49918047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016528880A Expired - Fee Related JP6661533B2 (ja) 2013-11-22 2014-11-21 ミトコンドリアを標的とするジカルボニル捕捉化合物

Country Status (12)

Country Link
US (1) US9963474B2 (cg-RX-API-DMAC7.html)
EP (2) EP3071582B1 (cg-RX-API-DMAC7.html)
JP (1) JP6661533B2 (cg-RX-API-DMAC7.html)
CN (1) CN105873936B (cg-RX-API-DMAC7.html)
AU (1) AU2014351802B2 (cg-RX-API-DMAC7.html)
CA (1) CA2931000A1 (cg-RX-API-DMAC7.html)
ES (1) ES2802123T3 (cg-RX-API-DMAC7.html)
GB (1) GB201320636D0 (cg-RX-API-DMAC7.html)
HK (1) HK1226079A1 (cg-RX-API-DMAC7.html)
SG (2) SG11201603485TA (cg-RX-API-DMAC7.html)
WO (1) WO2015075200A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201603129B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3562830B1 (en) * 2016-12-29 2023-06-07 Universidade do Porto Hydroxybenzoic acid derivatives, methods and uses thereof
JP6985730B2 (ja) * 2017-11-17 2021-12-22 株式会社日立ハイテクサイエンス 試料分析システム、表示方法及び試料分析方法
KR101920902B1 (ko) * 2017-12-27 2018-11-21 전남대학교 산학협력단 심혈관 질환 조기진단 pet 조영용 화합물 및 그의 용도
WO2020036329A1 (ko) * 2018-08-16 2020-02-20 숙명여자대학교산학협력단 미토콘드리아 내 nad(p)h 검출을 위한 형광 프로브 및 이를 이용한 검출방법
WO2020154731A1 (en) * 2019-01-25 2020-07-30 Mti Biotech, Inc. Triphenylphosphonium-tethered salicylamine derivatives
BR112021014696A2 (pt) 2019-01-25 2021-12-28 Univ Vanderbilt Sequestrantes isocetais/de isolevuglandina que têm mitocôndria como alvo
KR102596981B1 (ko) * 2019-10-30 2023-10-31 주식회사 퓨전바이오텍 미토콘드리아 표적 화합물 및 이를 포함하는 노화 관련 질환의 치료 또는 예방을 위한 조성물
CA3169467A1 (en) * 2020-01-27 2021-08-05 Sergey I. Dikalov Mitochondria-targeted isoketal/isolevuglandin scavengers and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB926998A (en) * 1960-04-25 1963-05-22 Ici Ltd New water-soluble azo dyestuffs containing phosphonium groups
JPS52806A (en) 1975-02-20 1977-01-06 Dai Ichi Kogyo Seiyaku Co Ltd Preparation of ester
JPS6029391B2 (ja) 1976-02-04 1985-07-10 富士写真フイルム株式会社 ベンゾトリアゾ−ル化合物
FR2776289B1 (fr) * 1998-03-20 2001-02-02 Oreal Composition de teinture d'oxydation contenant un coupleur cationique, procedes de teinture, nouveaux coupleurs cationiques
FR2776290B1 (fr) * 1998-03-20 2001-08-10 Oreal Nouveaux composes cationiques, leur utilisation comme coupleurs pour la teinture d'oxydation des fibres keratiniques, compositions tinctoriales et procedes de teinture
FR2788520B1 (fr) * 1999-01-19 2003-02-28 Oreal Nouveaux colorants mono-benzeniques cationiques, leur utilisation pour la teinture d'oxydation des fibres keratiniques, compositions tinctoriales et procedes de teinture
CA2431635A1 (en) * 2001-01-23 2002-08-01 P&G-Clairol, Inc. Couplers for oxidative coloration of hair
CN1678285A (zh) * 2002-09-02 2005-10-05 西巴特殊化学品控股有限公司 多孔材料的染色方法
EP1818063A1 (en) * 2004-12-02 2007-08-15 Japan Science and Technology Agency Medicine for treatment of disease caused by hyperstimulatory cytotoxicity and therapeutic method
US7956193B2 (en) 2007-05-04 2011-06-07 University Of South Florida Intramolecular C-H amination with sulfonyl azides
US8466140B2 (en) 2007-09-10 2013-06-18 University Of Massachusetts Mitochondria-targeted anti-tumor agents
FR2984321A1 (fr) * 2011-12-16 2013-06-21 Oreal Paraphenylenediamines cationiques, composition comprenant au moins de tels composes, procede de mise en oeuvre et utilisation
CN102617467A (zh) * 2012-02-21 2012-08-01 大连理工大学 一种检测一氧化氮的超高灵敏荧光探针
FR2996552B1 (fr) * 2012-08-17 2016-10-14 Oreal Composition tinctoriale comprenant un derive o-alkyle substitue de meta-phenylenediamine cationique

Similar Documents

Publication Publication Date Title
JP2017504561A5 (cg-RX-API-DMAC7.html)
JP2017526726A5 (cg-RX-API-DMAC7.html)
JP2017526677A5 (cg-RX-API-DMAC7.html)
JP2014518882A5 (cg-RX-API-DMAC7.html)
JP2017511815A5 (cg-RX-API-DMAC7.html)
RU2014131065A (ru) Димерные соединения-агонисты рецептора fgf ( fgfr ), способ их получения и их терапевтическое применение
JP2017517565A5 (cg-RX-API-DMAC7.html)
JP2016515561A5 (cg-RX-API-DMAC7.html)
JP2010523599A5 (cg-RX-API-DMAC7.html)
JP2013545817A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
JP2013010792A5 (cg-RX-API-DMAC7.html)
JP2019522055A5 (cg-RX-API-DMAC7.html)
JP2014508804A5 (cg-RX-API-DMAC7.html)
RU2017133011A (ru) B-d-2'-дезокси-2'-а-фтор-2'-в-с-замещенные-2-модифицированные-n6-замещенные пуриновые нуклеотиды для лечения вызванных hcv заболеваний
RU2017112048A (ru) Синергистические комбинации ауристана
JP2013544812A5 (cg-RX-API-DMAC7.html)
RU2018127728A (ru) Слитые трициклические гетероциклические соединения в качестве ингибиторов интегразы вич
RU2015149527A (ru) Производные доластатина 10 и ауристатинов
JP2020530007A5 (cg-RX-API-DMAC7.html)
RU2015106434A (ru) Производные типа азаиндазола или диазаиндазола для лечения боли
RU2011123700A (ru) Нонапептид с противоопухолевой активностью
KR20150092243A (ko) 뉴클레오시드 키나제 우회 조성물 및 방법
JP2019535723A5 (cg-RX-API-DMAC7.html)
JP2013542267A5 (cg-RX-API-DMAC7.html)